India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:544081 has a market cap or net worth of INR 217.05 billion. The enterprise value is 220.77 billion.
| Market Cap | 217.05B |
| Enterprise Value | 220.77B |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 227.42M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.04% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 55.50M |
Valuation Ratios
The trailing PE ratio is 64.50 and the forward PE ratio is 45.48.
| PE Ratio | 64.50 |
| Forward PE | 45.48 |
| PS Ratio | 11.63 |
| PB Ratio | 12.87 |
| P/TBV Ratio | 13.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 65.61 |
| EV / Sales | 11.83 |
| EV / EBITDA | 44.56 |
| EV / EBIT | 48.34 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.00 |
| Debt / FCF | n/a |
| Interest Coverage | 10.56 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 14.82% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 10.56M |
| Profits Per Employee | 1.90M |
| Employee Count | 1,767 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544081 has paid 1.08 billion in taxes.
| Income Tax | 1.08B |
| Effective Tax Rate | 24.29% |
Stock Price Statistics
The stock price has decreased by -14.41% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -14.41% |
| 50-Day Moving Average | 1,087.41 |
| 200-Day Moving Average | 1,123.18 |
| Relative Strength Index (RSI) | 31.85 |
| Average Volume (20 Days) | 14,989 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544081 had revenue of INR 18.66 billion and earned 3.37 billion in profits. Earnings per share was 14.80.
| Revenue | 18.66B |
| Gross Profit | 9.86B |
| Operating Income | 4.57B |
| Pretax Income | 4.44B |
| Net Income | 3.37B |
| EBITDA | 4.95B |
| EBIT | 4.57B |
| Earnings Per Share (EPS) | 14.80 |
Balance Sheet
The company has 1.25 billion in cash and 4.97 billion in debt, giving a net cash position of -3.72 billion.
| Cash & Cash Equivalents | 1.25B |
| Total Debt | 4.97B |
| Net Cash | -3.72B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 16.86B |
| Book Value Per Share | 74.12 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 52.83%, with operating and profit margins of 24.47% and 18.03%.
| Gross Margin | 52.83% |
| Operating Margin | 24.47% |
| Pretax Margin | 23.82% |
| Profit Margin | 18.03% |
| EBITDA Margin | 26.55% |
| EBIT Margin | 24.47% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544081 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.04% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.55% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |